Understanding the Rise in Measles Cases and How to Prevent Them

The U.S. faces its largest measles outbreak in over 30 years due to declining vaccination rates. Experts highlight airborne transmission and stress the importance of community vaccination to stop the spread.
The United States is currently experiencing its most significant measles outbreak in over three decades, with at least 1,277 confirmed cases spread across 36 states and the District of Columbia. Experts from Virginia Tech highlight the primary causes behind this resurgence and emphasize practical steps to curb the spread.
According to Linsey Marr, an environmental engineer specializing in aerosol virus transmission, the resurgence is mainly due to declining vaccination rates. Despite being considered eliminated in 2000, measles has reemerged as vaccination coverage drops. Marr explains that measles spreads similarly to COVID-19 through tiny respiratory particles capable of lingering in the air for hours, even after an infected individual has left the vicinity. These particles can be inhaled by others, leading to new infections. Historical cases from the 1980s underline this airborne transmission, where unvaccinated children contracted the virus after brief exposure in medical clinics.
The transmission of measles is predominantly driven by human behavior, such as gatherings and travel, rather than weather conditions. Lisa M. Lee, an infectious disease epidemiologist, underscores the extreme contagiousness of measles—one unvaccinated person can infect up to 20 others, surpassing the spread rate of COVID-19.
Preventing this outbreak is entirely possible through vaccination. Achieving at least 95% vaccination coverage in communities is crucial to protect the most vulnerable, particularly children. The predominant vaccine regimen includes two doses—first at 12 months of age and second between 4 and 6 years old. Adults who have not been vaccinated or previously contracted measles can still be immunized. The combined efficacy of two vaccine doses is approximately 97%, with even a single dose offering around 93% protection.
As measles cases rise, health experts advise reconsidering vaccination, emphasizing the vaccine's safety and importance. Side effects are typically mild and temporary, including slight discomfort at the injection site or mild fever, which are far less severe than complications from the disease itself. Measles can cause serious health problems, such as ear infections leading to hearing loss, vision impairment, brain inflammation, and in severe cases, death—especially in young children.
The key to stopping the spread is community-wide vaccination efforts. Achieving high immunization rates can prevent future outbreaks and protect public health. Individuals are encouraged to consult healthcare providers for accurate information and to get vaccinated promptly.
Source: https://medicalxpress.com/news/2025-07-experts-measles-surge.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Genetic Connection Between Childhood Brain Disorder and Adult Parkinson's Disease Uncovered
New research uncovers a genetic connection between a rare childhood neurodevelopmental disorder and the development of Parkinson's disease in adults, highlighting shared cellular mechanisms and potential therapeutic targets.
New Research Reveals How Stress Affects Heart at the Molecular Level
New research from UC Davis reveals that stress triggers molecular changes in the heart, increasing inflammation and risk of cardiovascular disease. Learn how environmental and social stressors activate inflammatory pathways in the heart tissue.
Safety of Aqueous Humor Liquid Biopsy Confirmed in Pediatric Retinoblastoma Patients
Recent study confirms that aqueous humor liquid biopsy is a safe and effective procedure for children with retinoblastoma, with minimal risks and excellent safety outcomes.
Innovative High-Throughput Antibody Testing Platform to Accelerate Disease Research and Therapeutic Development
A new high-throughput antibody testing platform developed by University of Illinois researchers can rapidly generate and analyze large antibody libraries, accelerating disease research, vaccine development, and therapy discovery.



